Firstly, ORY-1001 treatment resulted in decreased cell proliferation of lung cancer cells, including H1299 and A549 cells, in a time and dose-dependent manner, but this effect was rescued in H1299 and A549 cells, when HK2 was over expressed (Figure 4A). The gene discussed is HK2; the disease is lung carcinoma.